State legislators and Democratic leaders are demanding Gov. Greg Abbott schedule a vote to fill the seat left vacant by the late Rep. Sylvester Turner.

Genentech (S. San Francisco, CA) has announced disappointing phase II trial results of its anti-CD18 monoclonal antibodies in treating heart attacks. Preliminary analysis of the data in June ...